![The headquarters of Valeant Pharmaceuticals International Inc. seen in Laval Quebec The headquarters of Valeant Pharmaceuticals International Inc., seen in Laval, Quebec on Nov. 9 2015.](https://api.time.com/wp-content/uploads/2016/04/valeant-pharmaceuticals-price-increase-on-widely-used-us-drugs.jpg?quality=85&w=2400)
Major U.S. drug manufacturers set steep price increases on popular drugs for arthritis, high cholesterol, asthma and other common ailments, according to an analysis of price data.
Reuters reports that the prices for four of the country’s top drugs increased more than 100% since 2011, while six other went up more than 50%. The issue of rising drug prices got new attention recently when Turing Pharmaceuticals was widely criticized for raising the price of Daraprim, a medication used for a rare infection, some 5,000%.
The new analysis, based on 2014 sales figures and pricing data, was presented to the eight companies that sell the top 10 drugs, and Reuters reports that none contested the findings. However, drug companies said prices may be set high to recoup investments in failed drugs and to support research and development of new treatments.
[Reuters]
More Must-Reads from TIME
- Welcome to the Noah Lyles Olympics
- Melinda French Gates Is Going It Alone
- What to Do if You Can’t Afford Your Medications
- How to Buy Groceries Without Breaking the Bank
- Sienna Miller Is the Reason to Watch Horizon
- Why So Many Bitcoin Mining Companies Are Pivoting to AI
- The 15 Best Movies to Watch on a Plane
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
Contact us at letters@time.com